LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Sex Hormone Levels Linked to Sudden Cardiac Arrest Risk

By LabMedica International staff writers
Posted on 15 Sep 2014
Image: Histopathology of a heart demonstrating fibrosis and myocardial disarray in hypertrophic cardiomyopathy from a case of sudden cardiac arrest (Photo courtesy of Candace H Schoppe, MD).
Image: Histopathology of a heart demonstrating fibrosis and myocardial disarray in hypertrophic cardiomyopathy from a case of sudden cardiac arrest (Photo courtesy of Candace H Schoppe, MD).
The measurement of the levels of sex hormones in patients' blood may identify patients likely to suffer a sudden cardiac arrest, a heart rhythm disorder that can be fatal in most patients.

Unlike heart attacks or myocardial infarction, which are typically caused by clogged coronary arteries reducing blood flow to the heart muscle, sudden cardiac arrest is the result of defective electrical impulses and patients may have little or no warning, and the disorder usually causes nearly instantaneous death.

Scientists at the Cedars-Sinai Medical Center (Los Angeles, CA, USA) and their colleagues measured blood hormone levels in 149 patients whose mean age was 64.1 ± 11.7 years, 73.2% of which were males who had a sudden cardiac arrest (SCA), and compared them with levels in 149 patients of a similar age and sex ratio, who had coronary artery disease but did not have sudden cardiac arrest. Testosterone and estradiol levels were measured from blood samples drawn at the time of the SCA event in cases and during a routine visit in controls.

Among SCA cases the median testosterone levels were significantly lower in males at 4.4 ng/mL compared to controls who did not have sudden cardiac arrest at 5.4 ng/mL. Median estradiol levels were higher in male SCA patients at 68 pg/mL compared to the controls at 52 pg/mL and female SCA cases median was 54 pg/mL compared to 36 pg/mL. Higher testosterone levels were associated with lower SCA risk only in males and higher estradiol levels were associated with higher SCA risk in both males and females.

Sumeet Chugh, MD, director of the Heart Rhythm Center in the Cedars-Sinai Heart Institute, said, “This is the first time it has been reported that there is an association between sex hormone levels and sudden cardiac arrest. While these findings need to be confirmed by other studies, they suggest that higher testosterone levels in men may offer protection from sudden cardiac arrest and lower levels of estrogen may protect both men and women.” The study was published on August 23, 2014, in the journal Heart Rhythm.

Related Links:

Cedars-Sinai Medical Center 


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more